http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019135830-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9769d7f28716c8f6f189c4154f83e5a5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
filingDate 2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ac46105394e41c027f416369832a020
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd4f771c3d0f99054436deec434d141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80bb9315906e843cf27689e41f879b68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70837aef85e500fe8b8918f946f52c26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2facd5022337450f8dcf688d359f8f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28298b337830995d19d43397e4bcff78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a20b6cb93f5e7a5ed580d1a1fc96b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f306b7d227b7c60f5cf0b1e2bdeae856
publicationDate 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019135830-A1
titleOfInvention Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin
abstract Crystalline polymorphous forms of rifaximin (INN), referred to as rifaximin a and rifaximin 3, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.
priorityDate 2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411809709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449596929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57461352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412009375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14455022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423592648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724

Total number of triples: 70.